Category: Uncategorized

  • New study results published by The Lancet Digital Health

    New study results published by The Lancet Digital Health

    March 5, 2024 – Last night, the results of the first large-scale study involving a bi-hormonal fully closed-loop system with individuals with type 1 diabetes were published, presenting the outcomes of the Inreda AP®. Over 70 individuals used the Inreda AP® for a period of 1 year. The results have been analysed by researchers and…

  • MDR CE certificate for Inreda AP®

    MDR CE certificate for Inreda AP®

    On the 16th of December 2023, Inreda Diabetic BV received a CE certificate for the Inreda AP® as evidence that it complies with the new European regulation for medical devices, which is the MDR (Medical Device Regulation). We are very proud of this achievement! From the old to the new legislation The Inreda AP® had…

  • 100.000 treatment days!

    100.000 treatment days!

    The holiday season is right around the corner and we, on behalf of Inreda Diabetic, wish everyone happy holidays! For us, the holidays are all about looking back on milestones of the past year. We achieved another very nice milestone at the end of the year, which we consider a gift. Together, the Inreda AP®…

  • Attention to diabetes during World Diabetes Day

    Attention to diabetes during World Diabetes Day

    Diabetes, one of the most underestimated diseases in the world. In the Netherlands, there are about 1.2 million people with diabetes, of whom about 10% are affected by type 1. Type 1 diabetes, a second-day job without ever having a break. Pricking, measuring, eating… all day long. Thoughts like: can I exercise? Can I eat…

  • The first results of a long-term study will be presented at EASD 2023

    The first results of a long-term study will be presented at EASD 2023

    This coming October, Inreda® Diabetic will be present at EASD 2023 in Hamburg. At this exhibition, we will make our debut with our own stand and will represent our company to spread word about the Inreda AP®. Thereby, the results of a first long-term study with the Inreda AP® will be presented! But, what is…

  • Say hello to the new logo!

    Say hello to the new logo!

    14 september 2023 – In recent years, Inreda® has grown into a company that helps more than 100 people normalising their lives with its solutions. Inreda® is there for people with type 1 diabetes, but we have more to offer. Currently, the company has more than 60 employees taking on more and more projects, studies…

  • Marathon of Enschede with the Inreda AP®

    Marathon of Enschede with the Inreda AP®

    May, 2 2023 – May, 2 2023 – Frank ran the Marathon of Enschede on April 16th, a real achievement. To prepare himself he also ran a half-marathon. He would like to share his experiences about running a marathon with an Inreda AP®! Read Frank’s story here: Last Sunday the day was finally here, it…

  • Podcast KIJK: Het Experiment

    Podcast KIJK: Het Experiment

    7 april 2023 – In de podcast KIJK: Het Experiment gaan Laurien Onderwater en Diederik Jekel in gesprek met wetenschappers en voeren ze zelf experimenten uit. Tijdens de eerste aflevering interviewen ze Robin! Hij heeft immers op zichzelf geëxperimenteerd om de ontwikkeling van de Inreda AP® mogelijk te maken. Ze zijn nieuwsgierig naar zijn verhalen…

  • NOS Jeugdjournaal visits during training with adolescents

    NOS Jeugdjournaal visits during training with adolescents

    January 13, 2023 – Last weekend, January 7th & 8th , a group of adolescents was trained and prepared to wear the Inreda AP® for three weeks for a study. Five adolescents were brave enough to start last weekend with a completely new treatment for them. To highlight these people for their brave decision to…

  • First adolescents started wearing the Inreda AP® for clinical trials

    First adolescents started wearing the Inreda AP® for clinical trials

    December 9th , 2022 – Last weekend on December 3rd, the first adolescents started wearing the Inreda AP®. Twenty adolescents with diabetes type 1 between the ages of 12 and 18 will wear the AP® in everyday life for three weeks. This is all as part of a clinical study in collaboration with Rijnstate Hospital…